Related Experiment Video
Updated: Mar 29, 2026
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
1.1K
Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation
Xuejuan Li1, Fangrui Ding1, Suxia Wang2
1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Scientific Reports
|December 5, 2015
Summary
Cyclosporine A stabilizes podocyte cytoskeleton by regulating WAVE1, a protein crucial for kidney function. This discovery offers a new target for treating proteinuric kidney diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Podocytes are key targets for antiproteinuric drugs.
- Cyclosporine A (CsA), a calcineurin inhibitor, treats proteinuric kidney diseases.
- CsA may stabilize podocyte cytoskeleton to reduce proteinuria.
Purpose of the Study:
- Investigate WAVE1's role in podocytes.
- Determine if CsA regulates WAVE1 in podocytes.
- Explore WAVE1 as a therapeutic target for proteinuric kidney diseases.
Main Methods:
- Expressed and localized WAVE1 in podocytes.
- Induced podocyte injury using puromycin aminonucleoside (PAN).
- Utilized co-immunoprecipitation and Western blotting to assess protein interactions and phosphorylation.
Main Results:
- WAVE1 is expressed in podocytes and its expression increases with PAN-induced injury.
- CsA restored WAVE1 expression and F-actin organization after PAN injury.
- Calcineurin directly interacts with and regulates WAVE1 phosphorylation in podocytes.
Conclusions:
- WAVE1 is a novel CsA target in podocytes.
- WAVE1 plays a role in maintaining podocyte foot process structure.
- WAVE1 may be a future therapeutic target for antiproteinuric treatments.
Related Concept Videos
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.6K
5.6K
00:50Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
02:54Canonical Wnt Signaling Pathway
10.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K
01:23Negative Regulator Molecules
38.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
01:45Positive Regulator Molecules
137.1K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.1K